Literature DB >> 1968194

Amphotericin-resistant invasive hepatosplenic candidiasis controlled by fluconazole.

K Jakab, E Kelemen, G Prinz, I Török.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1968194     DOI： 10.1016/0140-6736(90)90706-b

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

Authors:  D Debruyne
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

Review 2.  Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

3.  Hepatosplenic candidasis, a fatal disease?

Authors:  A Loeliger; M van Leeuwen; M Rozenberg-Arska; A W Dekker
Journal:  Infection       Date:  1992-11       Impact factor: 3.553

Review 4.  Systemic Candida infections.

Authors:  L A Grohskopf; V T Andriole
Journal:  Yale J Biol Med       Date:  1996 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.